Previous 10 | Next 10 |
TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which is building the leading horizontal platform for cell programmin...
Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes PR Newswire BOSTON , Aug. 19, 2021 /PRNewswire/ -- Ginkgo Bioworks , Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced a n...
Ginkgo Bioworks Provides First Half 2021 Update Ginkgo launched 11 new cell programs in the first half of 2021 and increased the estimate for total new programs by year end from 23 to 30 Several cell programs were delivered to customers or are nearing completion and are expe...
Synthetic-biology company Ginkgo Bioworks is getting set to go public by merging with Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) , a special purpose acquisition company ("SPAC"). At a market valuation of more than $17 billion, it's one of the largest SPAC deals yet. The offering...
Extraordinary General Meeting Scheduled for September 14, 2021 Soaring Eagle Acquisition Corp., a Cayman Islands exempted company limited by shares (the “Company” or “Soaring Eagle”) (Nasdaq: SRNG.U, SRNG, SRNG WS), announced today that it has...
Eight-Week Pilot Program Focuses on Identifying New SARS-CoV-2 Variants Entering the U.S. Initially launching at three major international airports: John F. Kennedy International Airport, Newark-Liberty International Airport and San Francisco International Airport Ma...
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology Partnership enables Antheia to broaden its pipeline of critical active pharmaceutical ingredients and key starting materials PR Newswire MENLO P...
Ginkgo Bioworks and Soaring Eagle Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement PR Newswire BOSTON and NEW YORK , Aug. 11, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soari...
Aldevron's Collaboration with Ginkgo Bioworks Yields Manufacturing Breakthrough for Vaccinia Capping Enzyme Used for Manufacturing of mRNA Vaccines PR Newswire FARGO, N.D. and BOSTON , Aug. 10, 2021 /PRNewswire/ -- Aldevron , a leading research t...
Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation Presentation and Q&A session scheduled for Wednesday, August 18, 2021 PR Newswire BOSTON , Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a bus...
News, Short Squeeze, Breakout and More Instantly...
Soaring Eagle Acquisition Corp. Company Name:
SRNG Stock Symbol:
NASDAQ Market:
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds The company announces the closing of its business combination with Soaring Eagle Acquisition Corp. Proceeds exceed $1.6 billion with major shareholders including ARK Investment Management ...